Cargando…
Adherence to the GOLD Guidelines in Primary Care: Data from the Swiss COPD Cohort
(1) Introduction: Chronic obstructive pulmonary disease (COPD) and its associated morbidity and mortality are a global burden on both affected patients and healthcare systems. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) issues guidelines with the aim of improving COPD managemen...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607923/ https://www.ncbi.nlm.nih.gov/pubmed/37892775 http://dx.doi.org/10.3390/jcm12206636 |
_version_ | 1785127657578430464 |
---|---|
author | Mangold, Veronika Boesing, Maria Berset, Camille Bridevaux, Pierre-Olivier Geiser, Thomas Joos Zellweger, Ladina Kohler, Malcolm Lüthi-Corridori, Giorgia Maier, Sabrina Miedinger, David Thurnheer, Robert von Garnier, Christophe Leuppi, Jörg Daniel |
author_facet | Mangold, Veronika Boesing, Maria Berset, Camille Bridevaux, Pierre-Olivier Geiser, Thomas Joos Zellweger, Ladina Kohler, Malcolm Lüthi-Corridori, Giorgia Maier, Sabrina Miedinger, David Thurnheer, Robert von Garnier, Christophe Leuppi, Jörg Daniel |
author_sort | Mangold, Veronika |
collection | PubMed |
description | (1) Introduction: Chronic obstructive pulmonary disease (COPD) and its associated morbidity and mortality are a global burden on both affected patients and healthcare systems. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) issues guidelines with the aim of improving COPD management. Previous studies reported significant variability in adherence to these recommendations. The objective of this study was to evaluate Swiss primary practitioners’ adherence to the GOLD guidelines for the pharmacological treatment of stable COPD. (2) Methods: We studied patients who were included in the Swiss COPD cohort study, an ongoing prospective study in a primary care setting, between 2015 and 2022. The key inclusion criteria are age ≥ 40 years, FEV1/FVC ratio < 70%, and a smoking history of at least 20 pack-years. Adherence to the GOLD guidelines was assessed per visit and over time. (3) Results: The data of 225 COPD patients (mean age 67 ± 9 years, 64% male) and their respective 1163 visits were analyzed. In 65% of visits (726/1121), treatment was prescribed according to the GOLD guidelines. Non-adherence was most common in GOLD groups A and B (64% and 33%) and mainly consisted of over-treatment (two long-acting bronchodilators in group A (98/195, 50%) and ICS in groups A (21/195, 11%) and B (198/808, 25%)). In group D, the prescriptions conformed with the guidelines in 99% of cases (109/108). Guideline adherence was associated with high symptom load (COPD Assessment Test) (OR 1.04, p = 0.002), high number of exacerbations (OR = 2.07, p < 0.001), asthma overlap (OR 3.36, p = 0.049), and diabetes mellitus (OR 2.82, p = 0.045). (4) Conclusion: These results confirm a conflict between the GOLD recommendations and primary practice, mainly concerning over-treatment in GOLD groups A and B. Patients with high symptom load, high exacerbation risk, asthma overlap, and diabetes mellitus are more likely to be treated in conformity with the guidelines. Further research is needed to uncover the reasons for the discrepancies and to design strategies for improvement. |
format | Online Article Text |
id | pubmed-10607923 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-106079232023-10-28 Adherence to the GOLD Guidelines in Primary Care: Data from the Swiss COPD Cohort Mangold, Veronika Boesing, Maria Berset, Camille Bridevaux, Pierre-Olivier Geiser, Thomas Joos Zellweger, Ladina Kohler, Malcolm Lüthi-Corridori, Giorgia Maier, Sabrina Miedinger, David Thurnheer, Robert von Garnier, Christophe Leuppi, Jörg Daniel J Clin Med Article (1) Introduction: Chronic obstructive pulmonary disease (COPD) and its associated morbidity and mortality are a global burden on both affected patients and healthcare systems. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) issues guidelines with the aim of improving COPD management. Previous studies reported significant variability in adherence to these recommendations. The objective of this study was to evaluate Swiss primary practitioners’ adherence to the GOLD guidelines for the pharmacological treatment of stable COPD. (2) Methods: We studied patients who were included in the Swiss COPD cohort study, an ongoing prospective study in a primary care setting, between 2015 and 2022. The key inclusion criteria are age ≥ 40 years, FEV1/FVC ratio < 70%, and a smoking history of at least 20 pack-years. Adherence to the GOLD guidelines was assessed per visit and over time. (3) Results: The data of 225 COPD patients (mean age 67 ± 9 years, 64% male) and their respective 1163 visits were analyzed. In 65% of visits (726/1121), treatment was prescribed according to the GOLD guidelines. Non-adherence was most common in GOLD groups A and B (64% and 33%) and mainly consisted of over-treatment (two long-acting bronchodilators in group A (98/195, 50%) and ICS in groups A (21/195, 11%) and B (198/808, 25%)). In group D, the prescriptions conformed with the guidelines in 99% of cases (109/108). Guideline adherence was associated with high symptom load (COPD Assessment Test) (OR 1.04, p = 0.002), high number of exacerbations (OR = 2.07, p < 0.001), asthma overlap (OR 3.36, p = 0.049), and diabetes mellitus (OR 2.82, p = 0.045). (4) Conclusion: These results confirm a conflict between the GOLD recommendations and primary practice, mainly concerning over-treatment in GOLD groups A and B. Patients with high symptom load, high exacerbation risk, asthma overlap, and diabetes mellitus are more likely to be treated in conformity with the guidelines. Further research is needed to uncover the reasons for the discrepancies and to design strategies for improvement. MDPI 2023-10-20 /pmc/articles/PMC10607923/ /pubmed/37892775 http://dx.doi.org/10.3390/jcm12206636 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Mangold, Veronika Boesing, Maria Berset, Camille Bridevaux, Pierre-Olivier Geiser, Thomas Joos Zellweger, Ladina Kohler, Malcolm Lüthi-Corridori, Giorgia Maier, Sabrina Miedinger, David Thurnheer, Robert von Garnier, Christophe Leuppi, Jörg Daniel Adherence to the GOLD Guidelines in Primary Care: Data from the Swiss COPD Cohort |
title | Adherence to the GOLD Guidelines in Primary Care: Data from the Swiss COPD Cohort |
title_full | Adherence to the GOLD Guidelines in Primary Care: Data from the Swiss COPD Cohort |
title_fullStr | Adherence to the GOLD Guidelines in Primary Care: Data from the Swiss COPD Cohort |
title_full_unstemmed | Adherence to the GOLD Guidelines in Primary Care: Data from the Swiss COPD Cohort |
title_short | Adherence to the GOLD Guidelines in Primary Care: Data from the Swiss COPD Cohort |
title_sort | adherence to the gold guidelines in primary care: data from the swiss copd cohort |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607923/ https://www.ncbi.nlm.nih.gov/pubmed/37892775 http://dx.doi.org/10.3390/jcm12206636 |
work_keys_str_mv | AT mangoldveronika adherencetothegoldguidelinesinprimarycaredatafromtheswisscopdcohort AT boesingmaria adherencetothegoldguidelinesinprimarycaredatafromtheswisscopdcohort AT bersetcamille adherencetothegoldguidelinesinprimarycaredatafromtheswisscopdcohort AT bridevauxpierreolivier adherencetothegoldguidelinesinprimarycaredatafromtheswisscopdcohort AT geiserthomas adherencetothegoldguidelinesinprimarycaredatafromtheswisscopdcohort AT jooszellwegerladina adherencetothegoldguidelinesinprimarycaredatafromtheswisscopdcohort AT kohlermalcolm adherencetothegoldguidelinesinprimarycaredatafromtheswisscopdcohort AT luthicorridorigiorgia adherencetothegoldguidelinesinprimarycaredatafromtheswisscopdcohort AT maiersabrina adherencetothegoldguidelinesinprimarycaredatafromtheswisscopdcohort AT miedingerdavid adherencetothegoldguidelinesinprimarycaredatafromtheswisscopdcohort AT thurnheerrobert adherencetothegoldguidelinesinprimarycaredatafromtheswisscopdcohort AT vongarnierchristophe adherencetothegoldguidelinesinprimarycaredatafromtheswisscopdcohort AT leuppijorgdaniel adherencetothegoldguidelinesinprimarycaredatafromtheswisscopdcohort |